World Blood Pathogen Reduction Markets

 

Regular Price: USD 2,450

Special Price USD 1,715

30% OFF

* Required Fields

Regular Price: USD 2,450

Special Price USD 1,715

PAY BY INVOICE

Be the first to review this product

This report focuses on those pathogen reduction technologies that address a broad range of blood pathogens. The role of potentially complementary or substitute products to these broader scope technologies, such as nucleic acid testing and artificial blood are discussed. This report begins with an analysis of the technologies that are expected to enter different markets, then discusses market dynamics and different target markets and sub-segments in which these technologies will compete. Finally, the report focuses on the strategy elements related to competition within the market.

Table of Contents

World Blood Pathogen Reduction Markets, OverviewExecutive SummaryExecutive SummaryIntroductionFocus of the Report and MethodologyBlood Pathogen and Immunological Transfusion RisksIntroduction to Main Industry ParticipantsWorld Blood Pathogen Reduction Markets, Product and Technology AnalysisTechnology Platform OverviewIntroductionAdoption of Marketed Technologies and Pipeline OutlookMarketed TechnologiesSolvent/DetergentFiltrationGamma IrradiationMethylene BlueCerus and Baxter: Helinx S-59 Psoralen Compound for Platelets and PlasmaTechnology OverviewEfficacy Against Pathogens and White Blood CellsToxicity and Damage to Blood ProductsCerus and Baxter: S-303 FRALE Compound for Red Blood CellsTechnology OverviewEfficacy Against Pathogens and White Blood CellsToxicity and Damage to Blood ProductsVitex: Inactine PENN110 for Red Blood CellsTechnology OverviewEfficacy Against Pathogens and White Blood CellsToxicity and Damage to Blood ProductsGambro PRT: Riboflavin for Platelets Plasma and Red Blood CellsTechnology OverviewEfficacy Against Pathogens and White Blood CellsToxicity and Damage to Blood ProductsOther Technology PlatformsAmerican Red Cross: Dimethylmethylene Blue for Platelets Plasma and Red Blood CellsMaxwell Technologies: Broad Spectrum Pulse Light Altachem: BionexSubstitutes and Complementary ProductsBlood TestsArtificial BloodBiopharmaceuticalsWorld Blood Pathogen Reduction Markets, Market AnalysisMarket OverviewIntroductionTotal Pathogen Reduction Market Revenue Forecasts and AssumptionsDemand Analysis and Regulatory IssuesBlood Banks and FDA MandatePhysiciansDrivers of Market AdoptionClosing the Testing Window: Zero Risk Blood SupplyDemonstrated Safety and EfficacyBroad Range of Pathogen Kill without Damage to Blood ProductsCost Reductions at Blood BanksRestraints to Market AdoptionBlood Banker and Physician HesitancyTesting for PathogensReimbursement IssuesSegment Analysis and Revenue ForecastsRed Blood CellsPlasmaPlateletsAncillary MarketsWorld Blood Pathogen Reduction Markets, Strategy AnalysisCompetitive AnalysisIndustry StructureBusiness Models and Partnership Deal StructureCompetitive FactorsR&D Expenditures and Cash PositionsSelected Industry DealsChallenges and StrategiesMarket AdoptionFast Regulatory ApprovalAwardsMarket Engineering Leadership AwardTechnology Leadership Award




Related Research

Release Date : 18-Sep-17

Region : North America

Release Date : 18-Sep-17

Region : North America

Release Date : 18-Sep-17

Region : North America

Release Date : 15-Sep-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.